Precision for Medicine Competitors and Similar CompaniesClear all

Precision for Medicine's competitors and similar companies include Envigo, ICON and Charles River Laboratories.

	Precision for Medicine Precision for Medicine is a precision medicine clinical research services organization.	Envigo Envigo is a company that provides research models and services.	ICON ICON is a clinical research organization that provides consulting, outsourced development, and commercialization services.	Charles River Laboratories Charles River Laboratories International is a company that provides drug discovery and non-clinical development solutions.
Founding Date	Founding Date 2013	Founding Date 2015	Founding Date 1990	Founding Date 1947
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare clinical research life sciences pharma	Tags Healthcare biotech clinical research drug development genetics pharma	Tags Healthcare biotech clinical research medical imaging outsourcing	Tags Healthcare clinical research healthcare staffing medical diagnostics
Locations	Locations Bethesda, US HQ Montréal, CA Paris, FR Berlin, DE Budapest, HU Genève, CH Genève, CH see more	Locations Indianapolis, US HQ Gannat, FR Jerusalem, IL Bresso, IT Desio, IT Udine, IT Horst, NL see more	Locations Dublin, IE HQ Villa Adelina, AR Sydney, AU Vienna, AT Minsk, BY Minsk, BY Mechelen, BE see more	Locations Wilmington, US HQ Melbourne, AU Beerse, BE Brussels, BE São Paulo, BR Laval, CA Saint Constant, CA see more
Employees	Employees 1,7802% increase	Employees 503	Employees 41,250	Employees 18,3002% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 19.2 b	Valuation ($) 9.6 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $8.3b (FY, 2025)	Revenue (est.) $4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $6.1b (FY, 2025)	Cost of goods $2.7b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $2.2b (FY, 2025)	Gross profit $1.3b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income $229.3m (FY, 2025)	Net income ($142.2m) (FY, 2025)
Operating ⚠
Countries	Countries 70 (Jul, 2020)	Countries N/A	Countries 53 (FY, 2021)	Countries 20 (FY, 2021)
Funding
Total funding raised	Total funding raised $ 225m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 34m